GlobeNewswire

ISELIN, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced that Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics, will participate in a panel discussion titled, “Take A Look At What's In Store For Wet AMD & Related Diabetic Eye Diseases,” at the Cantor ...

Primary Logo

Raised $25 million from a Series C financing Proceeds to advance development of first-in-class oncology pipeline across multiple indications DUBLIN, Ireland and BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced it has raised $25 million in a Series C financing. The financing round was supported by existing investors, including ARCH Venture ...

Primary Logo

WESTCHESTER, Ill., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today announced that its 2030 emissions reduction targets have been approved by the Science Based Targets initiative (SBTi) and are consistent with levels required to meet the goals set by the Paris Agreement. The targets covering greenhouse gas emissions from the Company’s operations (scopes 1 ...

Primary Logo

ATLANTA, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Monarch Private Capital, a nationally recognized ESG investment firm that develops, finances and manages a diversified portfolio of projects that generate both federal and state tax credits, is pleased to announce the financial closing of low-income housing tax credit (LIHTC) equity for a $30 million affordable housing development called the Cornerstone Apartments in Yukon, Oklahoma. The Cornerstone Apartments are located at Czech Hall ...

Primary Logo

ROCKVILLE, Md., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that Company’s Management will participate in the following upcoming investor conferences in December. Detail on the conferences can be found below. Alliance Global Partners Virtual SeriesFormat: Fireside chat and ...

Primary Logo

LANCASTER, Pa., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Kelly Mahler, OTD, OTR/L, a Pennsylvania-based Occupational Therapist and author, is excited to announce the release of her new interoception book and instructional resource, The Big Book of Interoception Games. The Big Book of Interoception Games is a compilation of 53 fun and playful activities for learners of all ages. The book focuses on the core concept of interoception—one of the hottest topics in neuroscience—and the sense ...

SAN DIEGO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 11,510,992, entitled Compositions and Methods for the Treatment of Viral Infections, for CD388, a highly potent, long-acting drug-Fc conjugate (DFC) designed to achieve universal ...

Primary Logo

CAMP HILL, Pa., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Harsco Corporation (NYSE: HSC), a global, market leading provider of environmental solutions for industrial and specialty waste streams, today announced that Company management will be participating in the following investor conferences: Truist Securities Industrials and Services SummitTuesday, December 6, 2022BMO 2022 Growth & ESG ConferenceWednesday, December 7, 2022 About Harsco Corporation Harsco Corporation (NYSE: HSC) is a ...

Primary Logo

SAN JOSE, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- OpsRamp, the digital operations management company, today announced a global partnership with Birlasoft, a global enterprise technology and IT services company and part of the CK Birla Group. OpsRamp’s AI-powered platform will help Birlasoft to deliver modern digital operations management solutions for hybrid and multi-cloud environments. OpsRamp’s AI-powered platform will enable Birlasoft to provide their customers with ...

BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced that David Meeker, M.D., Chair, Chief Executive Officer and President, will participate in a fireside chat at the BofA Securities 2022 Virtual Biotech SMID Cap ...

Primary Logo

NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) -- LifeSci Advisors, an investor relations and corporate communications firm focused on the healthcare sector, today announced the continued expansion of its digital health practice with the appointment of Caroline Paul as Managing Director. “Caroline’s background is a perfect fit for our growing digital health franchise, as we continue to add new clients in the sector,” said Mike Rice, Cofounder of LifeSci Advisors. “Going forward, LifeSci ...

Primary Logo

SAN FRANCISCO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Instawork, the leading platform for connecting businesses with skilled workers, announced today the platform's availability to hourly workers in the Tampa area looking to earn higher wages as holiday and end-of-year travel are expected to be the highest in years. In Tampa, the average hourly pay rate on the Instawork platform is $16.52 per hour, a vast improvement over the state's minimum wage of $11 per hour. That steep increase ...

ZUG, Switzerland and BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in a fireside chat at the 2022 BMO Growth & ESG Conference on Wednesday, December 7, 2022, at 1:00 p.m. ET. A replay of the webcast will be archived for 14 days following the presentation ...

Primary Logo

Funding supports advancement of samuraciclib, an oral CDK7 inhibitor, in combination with endocrine therapy for HR+, HER2- advanced breast cancer Adam Schayowitz, Ph.D., Vice President and Development Head, Breast Cancer, Colorectal Cancer and Melanoma, Pfizer Global Product Development, joins Scientific Advisory Board DUBLIN, Ireland and BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly ...

Primary Logo

60% Confirmed Disease Control Rate1 and 7.4 Months Median Time to Tumor Progression for Ewing Sarcoma First-Relapse Patients No Disease Progression Observed in Either First- or Second-Relapse Ewing Sarcoma Patients Who Achieved Confirmed Disease Control HOUSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using targeted protein inhibition and targeted protein degradation to develop therapies for ...

Primary Logo

ASHEVILLE, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Ecobot, the premier digital solution for pre-construction environmental permitting, is proud to be the 2022 winner of the AgTech/CleanTech Award at the NC TECH Awards. Winners were recognized at the NC TECH Awards Gala on Tuesday, Nov. 29. "Since 1995, the NC Tech Awards has honored excellence and innovation throughout North Carolina, representing the best and brightest," said Brooks Raiford, president and CEO of NC TECH. "As a ...

Monarch reports additional gold assays from its 2022 McKenzie Break drilling program.Notable high-grade, near-surface intersections include 35.9 g/t Au over 0.5 m (MK-22-353), 28.2 g/t Au over 0.66 m (MK-22-334), 17.2 g/t Au over 0.9 m (MK-22-357) and 12.65 g/t Au over 1.5 m (MK-22-335).The 2022 drilling program focused on expanding the proposed pit shell limits to the north and southwest.Since the publication of the 2021 mineral resource estimate (“MRE”), Monarch has drilled ...

Primary Logo

WINTER PARK, Fla., Dec. 01, 2022 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company”) today announced that it has priced an upsized underwritten public offering of 3,000,000 shares of its common stock at a price to the public of $19.00 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of its common stock. The offering is expected to close on December 5, 2022, subject to customary closing conditions.

Primary Logo

BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Axel Bolte, MSc, MBA, the company’s co-founder, president, and chief executive officer, will participate in a fireside chat at the BofA Securities Biotech SMID Cap Conference on Thursday, December 8, 2022, from 8:00-8:30am ET. A ...

Primary Logo

SAN DIEGO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will host an investor event featuring members of the Kura management team and investigators from KOMET-001, a Phase 1/2 clinical trial of ziftomenib, the Company’s potent and selective menin inhibitor. The in-person investor event and live webcast ...

Primary Logo